AstraZeneca India has launched Chronic Kidney Disease Academy, in collaboration with the Indian Society of Nephrology (ISN). The academy will offer module-based learning for clinicians to enable them to provide better kidney care to their patients. The training programme aims to cover the pathophysiology, presentation, diagnosis, complications and management of CKD. 

Through this programme, AstraZeneca and the Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients. 

The certificate training course on CKD's latest updates will train about 1000 primary care physicians through three interactive modules. The modules would chronologically focus on the burden and risk factors of CKD, followed by the holistic guidelines for the management of CKD and lastly on newer therapies for better CKD management with a focus on SGLT2i inhibitors. 

These modules will be delivered by 30 eminent nephrologists from across the country, who will serve as faculty for the programme. The faculty shall be available both online and offline for mentoring young nephrologists and aiding scientific support. The modules will be one hour each and will be delivered by the faculty members in three to four months duration over virtual mode. On completing the three modules, a certificate of participation that will be endorsed by AstraZeneca and ISN will be provided to all participants.